A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants

NCT07454291 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: taladegib
DRUG: nintedanib
DRUG: pirfenidone
DRUG: pirfenidone

Sponsor

Endeavor Biomedicines, Inc.